Your session is about to expire
← Back to Search
Adjuvant Chemotherapy for Non-Small Cell Lung Cancer
Study Summary
This trial is testing whether post-operative chemotherapy is better than radiographic surveillance for stage I or stage IIA non-small cell lung cancer patients.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Excluding my lung cancer, my health suggests I could live 5 more years.I have provided a tissue sample for a specific genetic test.I am 18 years old or older.My early-stage lung cancer was completely removed by surgery.I am open to being assigned to receive chemotherapy as part of the study.My surgical wounds have fully healed.I can follow the study rules and attend all appointments for 5 years.I am fully active or can carry out light work.
- Group 1: Observation
- Group 2: Adjuvant Chemotherapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there various venues where this experiment is being conducted in the state?
"Allegheny Health Network Research Institute in Pittsburgh, Pennsylvania, Mercy Oncology Research St. Louis in Saint Louis, Missouri and Highlands Oncology Group in Springdale, Arkansas are all participating sites for this research trial; 20 other medical centres have been recruited as well."
Is there any remaining availability to join this medical experiment?
"This experiment, first introduced on the 11th of September 2020 and updated most recently on the 1st November 2022, is presently seeking new participants according to data available on clinicaltrials.gov."
What is the current sample size of individuals participating in this clinical trial?
"The sponsor, Razor Genomics, has identified a need for 1050 participants that meet the study's eligibility requirements. The trial will operate out of Allegheny Health Network Research Institute in Pittsburgh and Mercy Oncology Research St. Louis within Missouri."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger